These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32387866)

  • 1. Letter to the Editor: Endocrine and diabetes clinical practice during national lockdown and post lockdown period.
    Panchangam RB; Kota SK; Mayilvaganan S
    Diabetes Metab Syndr; 2020; 14(4):479. PubMed ID: 32387866
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Vaishya R; Bahl S; Singh RP
    Diabetes Metab Syndr; 2020; 14(4):687-688. PubMed ID: 32442918
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
    Klonoff DC; Umpierrez GE
    Metabolism; 2020 Jul; 108():154224. PubMed ID: 32275971
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'.
    Ghoshal S;
    Diabetes Metab Syndr; 2020; 14(5):1541. PubMed ID: 32947752
    [No Abstract]   [Full Text] [Related]  

  • 5. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Ghosh A; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):273-276. PubMed ID: 32283497
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Giansanti D; Aprile I
    Telemed J E Health; 2020 Sep; 26(9):1123-1125. PubMed ID: 32456559
    [No Abstract]   [Full Text] [Related]  

  • 7. Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges.
    Banerjee M; Chakraborty S; Pal R
    J Diabetes Sci Technol; 2020 Jul; 14(4):714-715. PubMed ID: 32438820
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes care during COVID 19: Experience in telemedicine from a developing country.
    García-Villasante E; Baca-Carrasco V; Gutierrez-Ortiz C; Pinedo-Torres I
    Diabetes Metab Syndr; 2020; 14(5):1519. PubMed ID: 32795744
    [No Abstract]   [Full Text] [Related]  

  • 9. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)".
    Kumar Singh A; Singh R
    Diabetes Metab Syndr; 2020; 14(5):937-938. PubMed ID: 32593934
    [No Abstract]   [Full Text] [Related]  

  • 11. Active Telephonic Follow-up During COVID-19 Lockdown: Initial Experience.
    Pandey V; Srivastava V; Imran M; Mishra A
    Indian Pediatr; 2020 Aug; 57(8):769. PubMed ID: 32583807
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Viganò M; Voza A; Harari S; Eusebio A; Ripoll Pons M; Bordonali M; Preti V; Rumi MG; Badalamenti S; Aghemo A
    Telemed J E Health; 2020 Oct; 26(10):1206-1208. PubMed ID: 32434462
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Zhang J; Wang H; Dong L
    Telemed J E Health; 2020 Jul; 26(7):853-854. PubMed ID: 32315253
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19, India, lockdown and psychosocial challenges: What next?
    Golechha M
    Int J Soc Psychiatry; 2020 Dec; 66(8):830-832. PubMed ID: 32536246
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor: "Telehealth and Telemedicine in the COVID-19 Era: A World of Opportunities for the Neurosurgeon".
    Rahman MM; Azam MG; Bohorquez-Rivero J; Garcia-Ballestas E; Agrawal A; Moscote-Salazar LR; Ahmed Khan R
    World Neurosurg; 2020 Oct; 142():541-542. PubMed ID: 32585376
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the Editor in response to the article: "Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis" (Ghoshal et al.).
    Chand R; Asmil SH; Chico M
    Diabetes Metab Syndr; 2020; 14(5):1305. PubMed ID: 32755826
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to editor - Can universal masking help with our recovery from the COVID-19 pandemic?
    Chiang CH; Chiang CH; Chiang CH
    Int J Surg; 2020 Jul; 79():125-126. PubMed ID: 32450263
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19.
    Mukhtar S; Mukhtar S
    Metabolism; 2020 Jul; 108():154248. PubMed ID: 32335075
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".
    Kokic Males V
    Diabetes Res Clin Pract; 2020 May; 163():108163. PubMed ID: 32333972
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Dunnigan A
    Telemed J E Health; 2020 Oct; 26(10):1209-1210. PubMed ID: 32471331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.